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Abstract
Importance—Human immunodeficiency virus (HIV) diagnoses continue to increase among 
young men who have sex with men (YMSM). Many YMSM living with HIV engage in sexual risk 
behaviors, and those who have a detectable viral load can transmit HIV to sex partners. 
Understanding factors that are related to sexual risk taking among virologically detectable (VL+) 
YMSM can inform prevention and treatment efforts.
Objectives—To describe differences between virologically suppressed (VL−) and VL+ YMSM 
living with HIV and to identify correlates of condomless anal intercourse (CAI) and 
serodiscordant CAI among VL+ YMSM.
Design, Setting, and Participants—In this cross-sectional survey conducted from December 
1, 2009, through June 30, 2012, we studied 991 HIV-infected YMSM 15 to 26 years of age at 20 
adolescent HIV clinics in the United States. Data analysis was conducted December 1, 2013, 
through July 31, 2015.
Main Outcomes and Measures—Demographic, behavioral, and psychosocial assessments 
obtained using audio computer-assisted self-interviews. Viral load information was obtained via 
blood draw or medical record abstraction.
Results—Of the 991 participants, 688 (69.4%) were VL+ and 458 (46.2%) reported CAI, with 
310 (31.3%) reporting serodiscordant CAI in the past 3 months. The VL+ YMSM were more 
likely than the VL− YMSM to report CAI (detectable, 266 [54.7%]; suppressed, 91 [44.4%]; P = .
01) and serodiscordant CAI (detectable, 187 [34.9%]; suppressed, 57 [25.0%]; P < .01). 
Multivariable analyses indicated that among VL+ YMSM, those reporting problematic substance 
use were more likely to report CAI (adjusted odds ratio [AOR], 1.46; 95% CI, 1.02-2.10) and 
serodiscordant CAI (AOR, 1.45; 95% CI, 1.06-1.99). Black VL+ YMSM were less likely to report 
CAI (AOR, 0.63; 95% CI, 0.44-0.90) or serodiscordant CAI (AOR, 0.66; 95% CI, 0.46-0.94) 
compared with other VL+ YMSM. In addition, VL+ YMSM who disclosed their HIV status to sex 
partners were more likely to report CAI compared with nondisclosing YMSM (AOR, 1.35; 95% 
CI, 1.01-1.81). Transgender participants were less likely to report CAI than cisgender participants 
(AOR, 0.35; 95% CI, 0.14-0.85). Last, VL+ YMSM who reported currently being employed were 
less likely to report serodiscordant CAI than those who were unemployed (AOR,0.74; 95% CI, 
0.55-0.99).
Conclusions and Relevance—Targeted multilevel interventions are needed to reduce HIV 
transmission risk behaviors among YMSM living with HIV, particularly among those who are VL
+.
Human immunodeficiency virus(HIV) continues to disproportionately affect men who have 
sex with men (MSM) in the United States. The most recent seroprevalence data available 
from the US Centers for Disease Control and Prevention suggest that the HIV epidemic is 
increasing among MSM, whereas it is relatively stable in heterosexual populations.1,2 Young 
MSM (YMSM) (13-29 years of age) are particularly vulnerable to HIV infection. More than 
one-quarter of new infections in the United States occur in YMSM,1 and this population 
constitutes more than 70% of new HIV infections among youths.3 Black YMSM and young 
transgender women are subgroups disproportionately affected by HIV. In 2009, black 
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YMSM accounted for 61% of all new infections in the United States.1 Likewise, HIV 
prevalence among transgender women in the United States has been estimated to be more 
than 20%.3
It is critical to implement biomedical and behavioral strategies to reduce the likelihood of 
transmission via male-to-male sexual contact, the primary mode through which HIV is 
transmitted among MSM.4 In addition to condom use, chemoprophylaxis, and routine 
screening for HIV, treatment of HIV-infected individuals to improve their immune status and 
to suppress viral load drastically reduces the odds of transmission.5 A landmark 6-year, 
global research study5 found that early treatment and consistent adherence to antiretroviral 
treatment (ART) among HIV-infected individuals reduced transmission of HIV to uninfected 
sex partners by 96%. An ongoing observational trial of serodiscordant gay and heterosexual 
couples provides additional support for the efficacy of treating HIV-infected people to 
reduce onward transmission6 and suggests that the paradigm of treatment as prevention has 
great potential as a strategy to reduce HIV among MSM.
The success of treatment as prevention in reducing the number of new infections among 
YMSM in the United States relies on increasing levels of HIV testing, ART uptake, 
adherence, and viral suppression among HIV-infected YMSM. However, challenges persist 
in keeping YMSM engaged in care and adherent to ART. For example, one review study7 
suggested that only 51% of HIV-infected youths achieve viral suppression. Among MSM, 
rates of suppression are even lower. A modeling study8 found that only 34% of HIV-infected 
white MSM and 16% of HIV-infected black MSM achieve viral suppression. Other research 
has highlighted racial disparities in access to HIV care and uptake of treatment among HIV-
infected MSM9 and notably among YMSM.10
Those HIV-infected YMSM who are receiving care have perhaps the greatest chance among 
YMSM to be virally suppressed, although a recently conducted study11 of HIV-infected 
youths and adolescents in care suggested that, among behaviorally infected youths, only 
50% were currently receiving ART and only 27.1% were virally suppressed. Moreover, the 
study found that HIV-infected young men and gay- or bisexual-identified HIV-infected 
youths were less likely than HIV-infected young women and heterosexual HIV-infected 
youth, respectively, to be receiving ART.
Behavioral approaches to improve engagement in care and adherence to medication 
specifically may need to occur in tandem with interventions to reduce sexual risk behaviors, 
such as condomless anal intercourse (CAI). Numerous studies12-15 have found that many 
HIV-infected YMSM engage in risky sexual behaviors after their diagnosis. Young MSM 
who are not virally suppressed may be at particular risk to engage in sexual risk behaviors 
that serve to perpetuate HIV transmission.
Demographic factors, such as age, sex, race/ethnicity, and socioeconomic factors, and 
psychosocial factors, such as disclosure to sex partners, substance use, and poor mental 
health, are related to enhanced sexual risk among MSM.9,16-18 However, few studies have 
explored these factors specifically among HIV-infected YMSM who are virologically 
detectable.
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The current study has 2 aims: (1) to describe differences in demographic and psychosocial 
factors between virologically suppressed (VL−) and virologically detectable (VL+) HIV-
infected YMSM who are currently in care and (2) to identify psychosocial factors associated 
with any CAI and serodiscordant CAI in the past 3 months among VL+ HIV-infected 
YMSM.
Methods
Sample
From December 1,2009, through June 30, 2012, a total of 2225 HIV-infected youths linked 
to care at clinics associated with the Adolescent Medicine Trials Network for HIV/AIDS 
Interventions (ATN) were recruited to participate in a cross-sectional survey. The 20 clinics 
were located in major US cities and Puerto Rico (see Acknowledgments section for specific 
locations of clinics). Data analysis was conducted December 1, 2013, through July 31, 2015.
To be eligible, youths had to be (1) 12 through 26 years of age, (2) living with HIV/AIDS, 
(3) aware they were HIV infected, (4) linked to care in one of the ATN's clinical sites or 
affiliates (eg, had at least one clinic visit during the enrollment period), and (5) able to 
understand English or Spanish. The study was approved by the institutional review boards at 
all participating sites and those from the members of the protocol team. The current study 
focuses on a subsample of participants whose birth sex was male (regardless of their current 
gender identity) and who reported sexual behavior (ie, oral or anal intercourse) with another 
male in the 3 months before the survey (991 [44.5%] of the total sample). The Figure shows 
the flow of the participants throughout the study.
Research staff approached all youth who met eligibility criteria during one of their 
scheduled clinic visits. After a thorough explanation of the study, staff obtained signed 
written informed consent or assent from youths agreeing to participate. Within 2 weeks of 
providing consent or assent, participants completed audio computer-assisted self-interviews 
to assess psychosocial and health factors, which took approximately 45 to 90 minutes. 
Health-related data, including most recent viral load, were also abstracted from participants' 
medical records. In a few cases in which recent (within the 6 months before study 
enrollment) viral load data were not available, blood samples were taken for measurement. 
Participants were given a small incentive determined by the sites' institutional review boards 
as compensation for their time.
Measures
The assessment measured 3 primary constructs: (1) substance use, (2) mental health, and (3) 
sexual behavior. The assessment also obtained demographic information, including age, 
birth sex, current gender identity, race/ethnicity, sexual orientation, route of HIV infection, 
housing status, incarceration history, and disclosure of HIV status to sexual partners. Health-
related data abstracted from medical records included whether the participant was prescribed 
ART (dichotomous variable), the date ART was prescribed (dichotomized into 2 groups: ≤6 
and >6 months since starting ART), the date of confirmatory HIV diagnosis (dichotomized 
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into 2 groups: ≤6 and >6 months since diagnosis), and most recent viral load. Specific 
information on the measures and viral load assessments used follows.
Substance Use—The Alcohol, Smoking, and Substance Involvement Screening Test 
(ASSIST)19 was used to measure substance use behaviors, and the Car, Relax, Alone, 
Forget, Friends, Trouble (CRAFFT)20 was used to assess problematic substance use. Eight 
items on the ASSIST questionnaire were used to assess the frequency and consequences of 
substance use. The current study examined daily use of alcohol and marijuana because these 
were the main substances study participants reported using. CRAFFT is a 6-item measure 
designed to assess the consequences of alcohol and/or marijuana use by adolescents and 
young adults in clinical settings. Scores of 2 or higher are suggestive of problem substance 
use, abuse, and/or dependence.
Mental Health—Mental health issues were assessed with the Brief Symptom Inventory 
(BSI),21 which yields 9 primary symptom scales, and a Global Severity Index (GSI), which 
has norms based on age (ie, adolescent and adult) and sex. The GSI reflects an overall 
evaluation of a respondent's psychopathological status. The BSI depression and anxiety 
subscales and the GSI were used in the current analyses.
Sexual Behavior—A 38-item questionnaire was used to assess sexual behaviors during 
the past 90 days. Participants reported the number of male and female sex partners and the 
frequency of condomless oral, vaginal, and anal sexual activity with HIV-infected, HIV-
negative, and unknown-status male and female partners.
Viral Load—Plasma HIV RNAandCD4+ cell count data obtained within the last 6 months 
and type of assay were abstracted from medical records. Because of the variability in type of 
assay used across the study sites (ie, Versant HIV-1 RNA 3.0 [Siemens Diagnostics]; 
Amplicor HIV-1 Monitor – Standard/Ultrasensitive [F. Hoffmann-La Roche Ltd]; COBAS 
AmpliPrep/COBAS Taqman HIV-1 Test, versions 1.0 and 2.0 [F. Hoffmann-La Roche Ltd]; 
and RealTime HIV-1 Assay [Abbott Laboratories]), we used the corresponding assay cutoff 
for the lower limit of HIV RNA detection (all were <200 copies/mL; see Kahana et al11 for 
sensitivity analysis) and created a dichotomous variable to differentiate VL− and VL+ 
participants.
Statistical Analysis
Demographic, health-related (except for BSI subscales), and substance use variables were 
primarily nominal or ordinal and were transformed to dichotomous variables for analytical 
purposes. These variables were compared between VL− and VL+ participants using 
standard descriptive statistics. Given the time needed to achieve viral suppression after 
starting ART, YMSM who had been receiving ART for 6 months or less (175 [17.7%] of the 
sample) were excluded from the analyses comparing VL+ and VL− YMSM.
Logistic regression analyses were conducted to explore factors related to any CAI and 
serodiscordant CAI among the subsample of VL+ YMSM. We used generalized estimating 
equations with robust SE estimates to account for the correlation due to clustering of 
participants within clinics. Analyses occurred in 2 steps. Variables were examined in 
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univariable logistic regression models to test associations between each independent variable 
and the 2 CAI outcome variables. Factors that were observed to be statistically significant (P 
≤ .10) in univariable models were included in separate generalized estimating equation 
models predicting the 2 CAI outcome variables. Because of multicollinearity, the BSI 
depression and anxiety and GSI variables were each examined in separate multivariable 
models with other variables observed to be significant in the univariable analyses. Estimates 
for non-BSI variables included in the multivariable models did not differ among models with 
different BSI subscale variables; thus, estimates for non-BSI variables are presented from 
multivariable models that included the GSI variable. All analyses were conducted using 
SPSS statistical software, version 22.0 (SPSS Inc).
Results
Frequencies for variables included in the analyses are presented in Table 1. Just more than 
half (52.1%) of YMSM reported currently being prescribed ART. Nearly half (46.2%) of 
YMSM reported CAI in the past 3 months,whereas310(31.3%) reported serodiscordant CAI.
Demographic and Psychosocial Differences Between VL− and VL+ HIV-Infected YMSM
In total, 288 YMSM (29.1%) were VL−, whereas 688 (69.4%) were VL+; data were not 
available for 15 participants (1.5%). Excluding YMSM who were receiving ART for 6 
months or less, 233 (29.3%) were VL− and 549 (69.0%) were VL+. Table 1 gives the 
differences between VL− and VL+ YMSM on study variables. Compared with YMSM who 
were VL−, those who were VL+ were more likely to be 21 years or older and to have ever 
been incarcerated. The VL+ YMSM were less likely to be currently employed and to report 
a post–high school educational level compared with VL− YMSM. In addition, VL+ YMSM 
had significantly higher scores than VL− YMSM on the BSI depression and anxiety 
subscales and the GSI. The VL+ YMSM were also more likely to report any CAI and 
serodiscordant CAI compared with VL− YMSM.
Factors Associated With CAI Among VL+ HIV-Infected YMSM
Univariable analyses revealed several factors associated with any CAI and serodiscordant 
CAI during the past 3 months among VL+ YMSM (eTable in the Supplement). Variables 
that were negatively related to CAI included transgender gender identity and black or 
African American race, whereas those that were positively associated with CAI included 
disclosure of HIV status to sex partners, problematic substance use, daily alcohol use, and 
BSI depression and anxiety subscale and GSI scores. In addition, factors that were 
negatively associated with serodiscordant CAI included current employment and black or 
African American race, whereas those that were positively related to serodiscordant CAI 
included problematic substance use, daily alcohol use, and BSI depression and anxiety 
subscale and GSI scores.
Table 2 and Table 3 contain findings from the multivariable analyses. Transgender gender 
identity (adjusted odds ratio [AOR], 0.35; 95% CI, 0.14-0.85) and black or African 
American race (AOR, 0.64; 95% CI, 0.48-0.86) were negatively associated with CAI. 
Disclosure of HIV status to sex partners (AOR, 1.45; 95% CI, 1.08-1.94) and problematic 
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substance use (AOR, 1.14; 95% CI, 1.04-1.25) were positively associated with CAI. 
Variables observed to be negatively associated with serodiscordant CAI were current 
employment (AOR, 0.74; 95% CI, 0.55-0.99) and black or African American race (AOR, 
0.63; 95% CI, 0.47-0.84). Problematic substance use was positively associated with 
serodiscordant CAI (AOR, 1.10; 95% CI, 1.01-1.20).
Discussion
This study is among the first to examine factors associated with sexual risk behaviors among 
VL+ YMSM. Condomless anal intercourse occurred with a relatively high level of 
frequency among YMSM in our sample. Furthermore, VL+ YMSM were more likely to 
report sexual risk behaviors than VL− YMSM. Taken together, findings suggest that to 
achieve the full promise offered by treatment as prevention for YMSM living with HIV, it is 
critical to develop behavioral interventions to address sexual risk behavior.2
It was particularly troubling that in a sample of YMSM linked to care fewer than 3 in 10 
(29.1%) were VL−. This estimate is on the lowest end of the range observed in observational 
studies included in a recently conducted review7 of research examining the continuum of 
care for HIV-infected youth (ie, viral suppression rates ranged from 30% to 70%), 
suggesting stark disparities in viral suppression affecting HIV-infected YMSM.
Previous research22 has found disparities in ART uptake and adherence affecting youth 
living with HIV. Demographic (ie, age, educational level) and structural (ie, unemployment, 
incarceration) factors were related to being VL+ among the YMSM in our sample. Likewise, 
mental health problems and engagement in sexual risk behaviors were associated with being 
VL+ among participants. Research has suggested that a confluence of structural, 
psychological, and behavioral factors enhance vulnerability to poor health outcomes among 
MSM, notably those who are YMSM and racial/ethnic minority MSM.18,23-25
Univariable analyses revealed that a number of demographic, psychological, behavioral, and 
structural factors were associated with CAI in the subsample of YMSM with a detectable 
viral load. However, multivariable analyses revealed the independent positive associations of 
problematic substance use, nonblack race, unemployment, cisgender identity, and HIV status 
disclosure to sexual risk behaviors (ie, any CAI and/or serodiscordant CAI) among VL+ 
YMSM. Previous research has found that substance use is associated with sexual risk 
behavior among YMSM26,27 and also disrupts adherence and impedes uptake of ART.28,29 
Our findings suggest that substance use must continue to be a target of health promotion 
interventions targeting HIV-infected youth.
Findings from the study also illustrate the paradox described by Millet et al9 in which black 
MSM have lower levels of sexual risk behaviors yet are the most highly affected by HIV in 
the United States. In our study, VL+ black YMSM had a lower likelihood of engaging in 
sexual risk behaviors compared with VL+ YMSM of other racial/ethnic groups. This finding 
underscores the role that social network and structural factors play in explaining enhanced 
HIV vulnerability among black YMSM.9 Our finding that transgender participants were less 
likely to report CAI compared with cisgender participants highlights the need for more 
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research on the factors associated with high prevalence of HIV among transgender women. 
Similar to black YMSM, network-level factors, and not solely individual-level behaviors, 
may influence heightened risk for HIV in this population.3
The finding that YMSM who disclosed their HIV status to sex partners were more likely to 
report any CAI than those not disclosing their status is consistent with other research17 and 
may suggest that many YMSM in the sample engaged in serosorting as a harm reduction 
strategy, given the significant association of disclosure to any CAI but not to serodiscordant 
CAI. Last, our findings suggest that socioeconomic factors, such as unemployment, are 
associated with increased HIV transmission risk behaviors. More research is needed to 
examine the mechanisms through which structural-level factors, such as joblessness, are 
related to sexual risk. For example, socioeconomic stress resulting from unemployment and 
related factors may lead to externalizing symptoms, such as sensation seeking and the use of 
sex to avoid or alleviate negative affect, which have been linked to sexual risk behavior 
among sexually active MSM.18,30,31
Our study is limited in that we used a cross-sectional approach that does not permit for 
causal inference. As noted, the sample includes only HIV-infected YMSM who are linked to 
care and thus limits the generalizability of the findings. In addition, our sample included a 
small number of transgender participants. Future research is needed to explore the unique 
risk factors for poor health outcomes among HIV-infected transgender women. Despite these 
limitations, this research makes valuable contributions to our understanding of factors 
associated with viral detectability among HIV-infected YMSM and with sexual risk behavior 
among VL+ YMSM.
Conclusions
Our findings highlight the inadequacies of treatment as prevention as the sole risk reduction 
method among HIV-infected YMSM in the United States and speak to a greater need for 
behavioral approaches to improve ART uptake and ultimately achieve higher rates of viral 
suppression in this population. Combination HIV prevention and treatment interventions, 
which include behavioral, biomedical, and structural strategies to increase viral suppression 
and reduce HIV transmission risk behaviors, that target HIV-infected YMSM are needed. To 
truly curb HIV incidence among YMSM, we cannot solely rely on one strategy to prevent 
and treat HIV.
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At a Glance
• A total of 688 (69.4%) of the human immunodeficiency virus (HIV)–infected 
young men who have sex with men (YMSM) in the sample had a detectable 
viral load.
• The HIV-infected YMSM with a detectable viral load were more likely to report 
sexual risk behavior compared with those who were virally suppressed. More 
than half (266 [54.7%]) of detectable YMSM reported condomless anal 
intercourse (CAI), whereas 91 (44.4%) of those who were suppressed reported 
CAI (P = .01). Likewise, 187 (34.9%) of the detectable YMSM reported CAI 
with an HIV-negative partner, whereas only 57 (25.0%) of suppressed YMSM 
reported serodiscordant CAI (P < .01).
• Factors related to CAI among virally detectable YMSM included problematic 
substance use, nonblack race, disclosure of HIV to sex partners, cisgender 
identity, and current unemployment.
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Figure. Participant Flow Diagram
Blue shaded boxes represent subsamples examined in the current study. HIV indicates 
human immunodeficiency virus.
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Table 1
Variable Frequencies for Full Sample and Comparison Between VL− and VL+ 
Subsamples of 991 HIV-Infected YMSMa
Variable Full Sample (N = 991) VL− Subsample (n = 233) VL+ Subsample (n = 549) P Value
Age ≥21 y 352 (35.5) 61 (26.2) 216 (39.5) <.01
Current employment 437 (44.1) 121 (52.2) 217 (39.6) <.01
Post–high school educational level 410 (41.4) 124 (53.4) 190 (34.7) <.01
Transgender 54 (5.4) 8 (3.4) 33 (6.0) .14
Black race 628 (63.4) 144 (62.3) 348 (63.5) .76
Hispanic ethnicity 219 (22.1) 56 (24.0) 126 (23.1) .77
Ever incarcerated 358 (36.1) 72 (30.9) 215 (39.2) .03
Current unstable housing 54 (5.4) 9 (3.9) 32 (6.0) .25
Prescribed ART 516 (52.1) 225 (96.6) 89 (16.2) <.01
Receiving ART for ≤6 months 175 (17.7)
Disclosure to sex partners 464 (46.8) 108 (50.9) 246 (50.5) .92
CRAFFT, mean (SD) 2.7 (1.8) 2.7 (1.8) 2.7 (1.8) .79
Daily alcohol use 59 (6.0) 9 (4.1) 37 (7.3) .10
Daily marijuana use 265 (26.7) 55 (31.8) 155 (36.4) .29
BSI depression subscale score, mean (SD) 7.0 (6.1) 6.3 (5.7) 7.3 (6.2) .03
BSI anxiety subscale score, mean (SD) 5.4 (5.4) 4.7 (5.1) 5.7 (5.4) .02
BSI GSI score, mean (SD)b 1.0 (0.8) 0.9 (0.8) 1.1 (0.8) .03
CAI 458 (46.2) 91 (44.4) 266 (54.7) .01
Serodiscordant CAI 310 (31.3) 57 (25.0) 187 (34.9) .01
Abbreviations: ART, antiretroviral treatment; BSI, Brief Symptom Inventory; CAI, condomless anal Intercourse; CRAFFT, Car, Relax, Alone, 
Forget, Friends, Trouble (keywords in a screening questionnaire to identify at-risk teen substance abusers); GSI, Global Severity Index; HIV, 
human immunodeficiency virus; VL−, virologically suppressed; VL+, virologically detectable; YMSM, young men who have sex with men.
a
Data are presented as number (percentage) unless otherwise indicated.
b
The BSI GSI criteria for clinically indicative symptoms are as follows: males 19 years or younger with GSI scores of 1.71 or higher, females 19 
years or younger with GSI scores of 1.59 or higher, males 20 years or older with GSI scores of 0.58 or higher, and females 20 years or older with 
GSI scores of 0.78 or higher.
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Table 2
Multivariable Analysis Predicting Condomless Anal Intercourse in Past 3 Months Among 
688 VL+ HIV-Infected YMSM
Variable Odds Ratio (95% CI)
Transgender 0.35 (0.14-0.85)a
Black race 0.35 (0.14-0.85)a
Disclosure to sex partners 0.63 (0.44-0.90)b
CRAFFT score ≥2 1.35 (1.01-1.81)a
Daily alcohol use 1.46 (1.02-2.10)a
BSI depression subscale scorec 1.86 (0.90-3.83)
BSI anxiety subscale scorec 0.98 (0.96-1.01)
BSI GSI scorec 0.98 (0.95-1.02)
Abbreviations: BSI, Brief Symptom Inventory; CRAFFT, Car, Relax, Alone, Forget, Friends, Trouble (keywords in a screening questionnaire to 
identify at-risk teen substance abusers); GSI, Global Severity Index; HIV, human immunodeficiency virus; VL+, virologically detectable; YMSM, 
young men who have sex with men.
aP ≤ .05.
bP ≤ .01.
c
The BSI depression and anxiety and GSI variables were tested in separate multivariate models because of multicollinearity.
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Table 3
Multivariable Analysis Predicting Serodiscordant Condomless Anal Intercourse in Past 3 
Months Among 688 VL+ HIV-Infected YMSM
Variable Odds Ratio (95% CI)
Current employment 0.76 (0.58-0.99)a
Black race 0.66 (0.46-0.94)a
CRAFFT score ≥2 1.45 (1.06-1.99)a
Daily alcohol use 1.52 (0.92-2.53)
BSI depression subscale scoreb 0.98 (0.95-1.00)
BSI anxiety subscale scoreb 0.99 (0.97-1.02)
BSI GSI scoreb 0.90 (0.74-1.09)
Abbreviations: BSI, Brief Symptom Inventory; CRAFFT, Car, Relax, Alone, Forget, Friends, Trouble (keywords in a screening questionnaire to 
identify at-risk teen substance abusers); GSI, Global Severity Index; HIV, human immunodeficiency virus; VL+, virologically detectable; YMSM, 
young men who have sex with men.
aP ≤.05.
b
The BSI depression and anxiety and GSI variables were tested in separate multivariate models because of multicollinearity.
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